載入...
Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers
PURPOSE: Epidermal growth factor receptor (EGFR) mutations have been found in the majority of gefitinib-responsive non-small cell lung cancer (NSCLC) patients from retrospective studies. We sought to compile the available phase II and prospective trials of this EGFR tyrosine kinase inhibitor (TKI) t...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2007
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2551312/ https://ncbi.nlm.nih.gov/pubmed/17610986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2007.05.017 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|